Current Opinion in Allergy and Clinical Immunology

Scope & Guideline

Navigating the latest trends in immunology and allergy management.

Introduction

Welcome to your portal for understanding Current Opinion in Allergy and Clinical Immunology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1528-4050
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2001 to 2024
AbbreviationCURR OPIN ALLERGY CL / Curr. Opin. Allergy Clin. Immunol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

Current Opinion in Allergy and Clinical Immunology focuses on advancing the understanding of allergic diseases and their management through critical reviews and expert opinions. The journal encompasses a range of topics that connect basic immunological research with clinical practice, aiming to bridge the gap between laboratory findings and real-world applications.
  1. Clinical Management of Allergic Conditions:
    The journal emphasizes evidence-based clinical practices for managing various allergic conditions, including food allergies, asthma, and anaphylaxis.
  2. Innovative Therapeutic Approaches:
    There is a strong focus on novel therapeutic strategies, including the use of biologics and immunotherapy, to enhance patient outcomes in allergy treatment.
  3. Interdisciplinary Collaboration:
    The journal highlights the importance of collaboration among healthcare professionals, such as allergists, immunologists, and other specialists, to improve patient care and management.
  4. Research and Development in Allergy:
    Current Opinion in Allergy and Clinical Immunology discusses emerging research findings, including genetic insights and the role of the microbiome in allergic diseases.
  5. Patient-Centered Care and Health Disparities:
    The journal addresses the importance of understanding patient perspectives and health disparities in managing allergic diseases, aiming for more personalized and equitable care.
Current Opinion in Allergy and Clinical Immunology has identified several emerging and trending themes that reflect the latest advancements and shifts in research focus within the field of allergy and immunology.
  1. Artificial Intelligence in Allergy Management:
    The integration of artificial intelligence and machine learning in developing algorithms for managing allergies is gaining traction, indicating a trend towards technology-driven solutions.
  2. Personalized Medicine in Allergy Treatment:
    There is a notable increase in discussions around precision medicine, tailoring treatment strategies based on individual patient profiles and genetic factors.
  3. Impact of COVID-19 on Allergic Conditions:
    Research on the effects of the COVID-19 pandemic on allergies and asthma, including vaccine-related concerns and management during the pandemic, has emerged as a significant theme.
  4. Ocular Allergies and Eye Health:
    A growing body of literature is focusing on ocular allergies and the role of allergists in managing eye-related conditions, expanding the scope of allergic disease management.
  5. Food Allergy Innovations:
    Recent publications highlight new therapeutic strategies and research developments in food allergies, reflecting an increased focus on this area due to its rising prevalence.

Declining or Waning

As the field of allergy and immunology evolves, certain themes have seen a decline in prominence within the journal's publications. This reflects shifting research priorities and clinical practices.
  1. Traditional Allergen Immunotherapy:
    While allergen immunotherapy remains a key topic, the focus on traditional methods has waned in favor of more innovative approaches, such as biologics and precision medicine.
  2. Generalized Approaches to Anaphylaxis Management:
    There has been a shift towards more specific strategies and individualized treatment plans for anaphylaxis, leading to a decline in broad, generalized discussions.
  3. Basic Research on Allergic Mechanisms:
    Although foundational research is important, the journal's recent publications show a trend away from purely basic science towards more translational and clinical applications.
  4. Occupational Allergies:
    The frequency of papers specifically addressing occupational allergies has decreased, potentially indicating a shift in focus towards more prevalent or critical clinical issues.
  5. Older Pharmacotherapy Options:
    There is less emphasis on traditional pharmacotherapy methods, as the journal increasingly highlights novel treatments and evidence-based approaches.

Similar Journals

CURRENT ALLERGY AND ASTHMA REPORTS

Transforming Knowledge into Practice in Respiratory Health
Publisher: CURRENT MEDICINE GROUPISSN: 1529-7322Frequency: 12 issues/year

CURRENT ALLERGY AND ASTHMA REPORTS, published by CURRENT MEDICINE GROUP, is a premier journal dedicated to advancing knowledge in the fields of allergy, asthma, and pulmonary medicine. With an impressive impact factor and a distinguished position in the Scopus ranking system—holding the 12th spot in Pulmonary and Respiratory Medicine and 40th in Immunology and Allergy—this journal is vital for researchers, clinicians, and healthcare professionals aiming to stay abreast of the latest developments and evidence-based practices. Since its inception in 2001, the journal has committed to publishing rigorous research articles, reviews, and expert opinion pieces that inform both clinical practice and research initiatives. Although it does not currently offer open access, it continues to maintain a robust platform for disseminating critical findings and fostering scholarly dialogue, ensuring it remains an essential resource for those dedicated to improving patient outcomes in respiratory health.

ALLERGY AND ASTHMA PROCEEDINGS

Pioneering the future of Allergy and Asthma treatments.
Publisher: OCEAN SIDE PUBLICATIONS INCISSN: 1088-5412Frequency: 6 issues/year

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Pioneering research for a healthier tomorrow.
Publisher: ESMON PUBLICIDAD S A, DEPT ALLERGY & CLIN IMMUNOL, CLIN UNIV NAVARRAISSN: 1018-9068Frequency: 6 issues/year

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

Fostering innovation for better patient care.
Publisher: ALLERGY IMMUNOL SOC THAILANDISSN: 0125-877XFrequency: 4 issues/year

The ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, published by the Allergy Immunology Society of Thailand, is a pivotal platform for disseminating high-quality research in the fields of allergy and immunology. Established in 1983, this journal has consistently evolved to address the pressing challenges and advancements in these dynamic disciplines, contributing significantly to the global scientific community's understanding of immunological disorders. With a category ranking of Q3 in Immunology and Allergy, and Q2 in Medicine (miscellaneous) for 2023, the journal stands at the forefront of impactful research, engaging with a diverse audience of researchers, clinicians, and students alike. Although it operates on a non-open access model, its rigorous peer-review process ensures that published articles meet the highest academic standards. Located in Bangkok, Thailand, the journal connects researchers across the Asia-Pacific region, fostering collaboration and innovation to enhance patient care in the realm of allergy and immunology.

Current Treatment Options in Allergy

Bridging Research and Practice in Allergy Medicine
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Allergy is an esteemed academic journal published by SpringerNature, focusing on a critical area of health science: the evolving landscape of allergy treatments. With an E-ISSN of 2196-3053, this journal aims to provide a comprehensive platform for researchers and practitioners in the fields of Immunology and Allergy and Medicine. It has garnered recognition in the academic community, reflecting its significant contribution with a Q3 ranking in Immunology and Allergy and a Q3 ranking in Medicine as of 2023. The journal is based in Switzerland and encompasses research spanning from 2014 to 2024, ensuring that the latest findings and treatment options are available to professionals and students alike. With a growing focus on open access, it aims to make critical allergy treatment research widely accessible, thus fostering innovation and collaboration in this vital health sector. As the prevalence of allergies continues to rise globally, Current Treatment Options in Allergy plays a crucial role in disseminating important research and treatment strategies to improve patient outcomes.

AIMS Allergy and Immunology

Fostering Excellence in Allergy and Immunology Scholarship
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2575-615XFrequency: 4 issues/year

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Advancing the Frontiers of Allergy and Immunology
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Exploring breakthroughs in allergic diseases and immune responses.
Publisher: MOSBY-ELSEVIERISSN: 0091-6749Frequency: 12 issues/year

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.

Therapeutic Advances in Allergy and Rhinology

Empowering researchers and clinicians in allergy and rhinology.
Publisher: SAGE PUBLICATIONS INCISSN: 2753-4030Frequency: 1 issue/year

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

Egyptian Journal of Pediatric Allergy and Immunology

Empowering healthcare professionals with cutting-edge insights.
Publisher: EGYPTIAN SOC PEDIATRIC ALLERGY & IMMUNOLOGYISSN: 1687-1642Frequency: 2 issues/year

Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.